PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

🧠 Clinical library

Clinical Specialty Index

551 articles indexed across 24 specialties, each reviewed by a licensed pharmacist before publication.

⭐ Featured free samples

Three of our best full deep-analysis reports: hand-picked, free to read in full, no subscription required.

🔓 Free Sample
Nephrology / Renal Pharmacy ConfirmatoryGrade: Moderate

Finerenone Outperforms Spironolactone for Cardiorenal Protection in Moderate CKD

Finerenone emerges as the safer choice for CKD patients.

Read Free →
🔓 Free Sample
Neurology / Neuropharmacology ConfirmatoryGrade: Low

Tenecteplase Shortens Stroke Treatment and Transfer Times

Tenecteplase speeds up stroke thrombolysis compared to alteplase.

Read Free →
🔓 Free Sample
Rheumatology / Immunology ConfirmatoryGrade: Moderate

EULAR 2025 Streamlines Rheumatoid Arthritis DMARD Management to Nine Recommendations

New EULAR guidelines redefine RA management with DMARDs.

Read Free →
Showing 6 from 1 topic.Sort: Newest | Oldest
Medicare Claims Study Tracks Endocrinologist Uptake of 2019 ADA SGLT2i and GLP-1 RA Guidance
Guideline Endocrinology / Obesity Confirmatory Grade: Low

Guideline updates boost SGLT2 inhibitor prescribing for diabetes care.

Polish Psychiatric Association Guides Metabolic Risk Management in Antipsychotic Users
★ Editor's Pick Guideline Psychiatry / Psychopharmacology Practice-changing Grade: Moderate
Also in Endocrinology / Obesity

Prevent metabolic disorders in patients on antipsychotics with early screening and metformin.

SEEP Consensus on Pediatric Type 1 Diabetes in Special Situations
Guideline Pediatric Pharmacy Practice-changing Grade: Low
Also in Endocrinology / Obesity

New consensus guides T1D management in special situations for children and adolescents.

ADA Obesity Association Releases 2026 Adult Obesity Diagnosis and Staging Standards
Guideline Endocrinology / Obesity Practice-changing Grade: Moderate

New obesity guidelines emphasize early screening and tailored diagnosis.

ADA 2026 Standards of Care Section 16 Refines Inpatient Diabetes Management Across Glycemia, Technology, and Perioperative Care
Guideline Endocrinology / Obesity Confirmatory Grade: Moderate

New ADA guidelines for inpatient diabetes management unveiled.

ADA 2026 Standards: New Guidance Across Cardiorenal, HFpEF, and MASH in Diabetes Care
Guideline Endocrinology / Obesity Practice-changing Grade: Moderate

Understand the latest ADA guidelines for diabetes medication management in 2026.